Advisory Services Network’s Amneal Pharmaceuticals AMRX Stock Holding History

Advisory Services Network’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.3K	Buy	+5,015	New	+$67.3K	﹤0.01%	2489
2025 Q4	–	Sell	-5,015	Closed	-$50.2K	–	1895
2025 Q3	$50.2K	Buy	+5,015	New	+$45K	﹤0.01%	2460
2021 Q3	–	Sell	-1,000	Closed	-$5K	–	1462
2021 Q2	$5K	Buy	+1,000	New	+$5.68K	﹤0.01%	3041
2021 Q1	–	Sell	-675	Closed	-$3K	–	1350
2020 Q4	$3K	Sell	675 -362	-35%	-$1.6K	﹤0.01%	2846
2020 Q3	$4K	Buy	+1,037	New	+$4.43K	﹤0.01%	2822
2020 Q1	–	Sell	-40	Closed	–	–	3009
2019 Q4	$0	Hold	40	–	–	﹤0.01%	3067
2019 Q3	$0	Hold	40	–	–	﹤0.01%	2793
2019 Q2	$0	Sell	40 -137	-77%	-$1.4K	﹤0.01%	2791
2019 Q1	$3K	Sell	177 -260	-59%	-$3.44K	﹤0.01%	2214
2018 Q4	$6K	Buy	437 +347	+386%	+$6.25K	﹤0.01%	1941
2018 Q3	$2K	Buy	+90	New	+$1.89K	﹤0.01%	2286

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Advisory Services Network's AMRX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Amneal Pharmaceuticals (AMRX) in Q1 2026: 5,015 shares worth $62.3K. The stake represents ﹤0.01% of the portfolio and ranks #2489 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in AMRX as recently as Q3 2025.

Advisory Services Network first reported a position in AMRX in Q3 2018 and has held it in 11 quarters since. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Advisory Services Network held 5,015 shares of Amneal Pharmaceuticals worth $62.3K as of Q1 2026.
Amneal Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2489 holding.
Advisory Services Network first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 11 quarters since.
315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.